Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

ETFs Benefit From Alibaba Earnings Pop

Published 08/17/2017, 12:52 PM
Updated 05/14/2017, 06:45 AM

On a weak equity tape today one stock that is popping after their quarterly earnings release is China based Alibaba Group Holdings Ltd. (NYSE:BABA).

The company, which was founded in 1999 debuted on the New York Stock Exchange nearly three years ago in September of 2014, has since then has achieved several feats such as growing into the world’s largest retailer (WMT was formerly the leader as of April of 2016).

Just last month, BABA became the first Asian based company to rise above the $400 billion mark in terms of its market capitalization, and with today’s lift in the stock clearly that value continues to rise. Today we see the stock trading at yet another all-time high following a warm reception to their quarterly earnings report, and this once again causes us to visit ETFs that are benefiting from their exposure to the stock.

ETFs that have a sizable allocation in BABA are as one might expect funds that are either China or Emerging-Markets based for the most part. BLDRS Emerging Markets 50 ADR (NASDAQ:ADRE) (Expense Ratio 0.30%) has the highest weighting to BABA with a notable 15.20% allocation, while there are several other funds with more than 10% slices dedicated to the stock.

In order of percentage allocations these ETFs are iShares MSCI China (NASDAQ:MCHI) (Expense Ratio 0.64%, 12.38% weighting), BLDRS Asia 50 ADR (NASDAQ:ADRA) (Expense Ratio 0.30%, 10.90%), Guggenheim Invest BRIC (NYSE:EEB) (Expense Ratio 0.64%, 10.86%), Guggenheim Invest China Technology (NYSE:CQQQ) (Expense Ratio 0.70%, 10.78%), First Trust International IPO (NASDAQ:FPXI) (Expense Ratio 0.70%, 10.68%) and SPDR S&P China (MX:GXC) (NYSE:GXC) (Expense Ratio 0.59%, 10.44%).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Being an ADR, BABA will not qualify as a holding in some ETFs, depending on how they are structured in terms of how they were initially set up, i.e. in spite of its rising market capitalization and prominence not only as a player in China but an international force, ETFs based on indices that do not incorporate ADRs will always miss out on exposure to the stock.

Significantly, when BABA debuted for trading back in 2014 S&P Dow Jones Indices assigned BABA a “China” domicile, making it ineligible for inclusion in well-known indices such as the S&P 500, the S&P MidCap 400 and the S&P SmallCap 600 indices since the investment criteria mandates a “U.S.” domicile.

Alibaba Group Holding

Alibaba Group Holding was trading at $167.83 per share on Thursday morning, up $8.33 (+5.22%). Year-to-date, BABA has gained 91.13%, versus a 10.76% rise in the benchmark S&P 500 index during the same period.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.